The Joint Action Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) Annual Event is being held between 7-9 November in Vienna, Austria. At the working group activities (workshops) for different work practices and the General Assembly annual meeting, EMSA is represented by our Vice President for Internal Affairs Yordan Kovatchev.
EU-JAMRAI is a European Union Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI) that brings together 44 partners from 28 countries and more than 30 stakeholders. The aim is to foster synergies among EU Member States by developing and implementing effective “One Health” policies to fight the rising threat of AMR and to reduce HCAI.
The importance of fighting AMR at the European level: AMR does not recognize geographic borders and requires a coordinated global response. Strengthening national and international health security initiatives against the AMR challenge requires a common European approach. Co-funded by the Health Programme of the European Union and by the 28 participating countries, this Joint Action aims to bring more coherence to the European contribution to the global movement against AMR.
What are the objectives of EU-JAMRAI?
1. To identify and test evidence-based measures to address AMR and HCAI in different contexts and provide recommendations to policymakers.
2. To bring together different networks of policymakers, experts and organisations working on AMR and HCAI.
3. To promote: the “One Health” approach, “One Health” in all policies concept, Health in all policies concept.
4. To produce concrete recommendations and promote awareness and commitment by governments and stakeholders for a European contribution to international activities.
Antimicrobial Resistance cannot be tackled by policymakers alone. EU-JAMRAI is founded on the belief that AMR requires a cross-sectional response involving all key actors.
Nine work packages, each of them with specific objectives, address the main goal of the Joint Action: Coordination, Dissemination, Evaluation, Integration in national policies and sustainability, Implementation of “One Health” national strategies and national action plans for AMR, Policies for prevention of HCAIs and their implementation, Appropriate use of antimicrobials in humans and animals, Raising awareness and communication, Prioritizing and implementing research and innovation for public health needs.
#OneHealth #YesWeCare #AMR #HCAI